For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Here’s a happy ending
Wednesday 22 May 2024, 05:00 AM

Anna Mickell and Barbara Fountain – babes in the woods buying a media company in 2015 [Image: NZD]
Editor Barbara Fountain recounts some difficult times for the company, farewells her business partner Anna, and looks forward to still reporting for the sector
It’s been a tough couple of months arriving at this spot and my gratitude goes out to everyone who offered kind words of support and aroha to our team
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.